Medical Equipment

Global Transmucosal Drug Delivery Devices Industry Trends: Where the Market Is Headed by 2029

November 18, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Transmucosal Drug Delivery Devices Market Expected To Become By 2029 Compared With Its 2025 Level?

The transmucosal drug delivery devices market size has grown strongly in recent years. It will grow from $50.24 billion in 2024 to $54.63 billion in 2025 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to the need for rapid relief from angina, the effectiveness of sublingual delivery for quick absorption into the bloodstream, desire to bypass gastrointestinal degradation, development of buccal tablets, the need for non-invasive delivery of peptides and proteins.

The transmucosal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $76.06 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the development of smart drug delivery systems, increased prevalence of chronic diseases, growing focus on personalized medicine, aging population with higher medication needs, and increased awareness. Major trends in the forecast period include expansion in therapeutic applications, customizing drug delivery devices for personalized medicine, regulatory approvals and guidelines, emerging markets, eco-friendly devices, and innovative formulations.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16812&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Transmucosal Drug Delivery Devices Industry?

The growing prevalence of chronic diseases is expected to propel the growth of the transmucosal drug delivery devices market going forward. A chronic disease refers to a long-lasting condition that typically progresses slowly and persists over time, often requiring ongoing medical management to control symptoms and prevent complications. Chronic diseases are rising as a result of, lifestyle factors, aging populations, environmental factors, healthcare system challenges, and urbanization. Transmucosal drug delivery devices are used in chronic diseases to provide controlled and efficient delivery of medications, ensuring sustained therapeutic levels for managing symptoms and improving patient adherence. For instance, in August 2023, according to a report published by the Leukemia & Lymphoma Society (LLS), a US-based charitable organization, in the US, approximately every three minutes, someone is diagnosed with leukemia, lymphoma, or myeloma. In 2023, an estimated 184,720 individuals are expected to receive these diagnoses, representing 9.4% of the projected 1,958,310 new cancer cases for the year. Therefore, growing prevalence of chronic diseases is driving the transmucosal drug delivery devices market.

What Are The Emerging Segments Gaining Attention In The Transmucosal Drug Delivery Devices Market?

The transmucosal drug delivery devicesmarket covered in this report is segmented –

1) By Type: Passive Transdermal Drug Delivery, Active Transdermal Drug Delivery

2) By Drug Type: Buccal Tablets, Oral Sprays, Sublingual Films And Wafers, Gels, Medicated Confectionery, Other Drug Types

3) By Indication: Pain Management, Addiction Treatment, Hormonal Therapies, Others Indications

4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals

Subsegments:

1) By Passive Transdermal Drug Delivery: Reservoir Systems, Matrix Systems, Micro-Needle Systems, Pressure-Sensitive Adhesive Systems

2) By Active Transdermal Drug Delivery: Iontophoresis, Sonophoresis, Electroporation, Thermal Ablation, Microporation

Which Market Trends Are Creating New Opportunities In The Transmucosal Drug Delivery Devices Industry?

Major companies operating in transmucosal drug delivery devices are developing innovative smart platform, such as proprietary transdermal patch delivery platforms that enhance drug absorption and improve patient compliance and convenience. Proprietary transdermal patch delivery platforms refer to specialized technologies owned by companies for administering medications through the skin, ensuring controlled release, and enhanced therapeutic outcomes. For instance, in January 2024, Starton Therapeutics Inc, a US-based biotechnology company, launched STARSILON, a novel proprietary transdermal patch delivery platform, for a longer duration to achieve therapeutic delivery of difficult-to-formulate APIs. It expands transdermal drug delivery options for challenging active pharmaceutical ingredients (APIs), enhancing therapeutic efficacy with sustained delivery rates.

Which Industry Leaders Are Driving Innovation Across The Transmucosal Drug Delivery Devices Market?

Major companies operating in the transmucosal drug delivery devices market are Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup, Glenmark Pharmaceuticals Limited, Stevanato Group S.p.A, Lifevision Healthcare Private Limited, Noven Pharmaceuticals, SAVA Healthcare Limited, Antares Pharma Inc., Kaizen Pharmaceuticals Pvt. Ltd., Lucky Pharma Pvt. Ltd., Maya Biotech Pvt. Ltd, AdvaCare Pharma LLP, Satsuma Pharmaceuticals Inc., Biophar Lifesciences Private Limited, Fibovil Pharmaceuticals Private Limited, Slan Medicinal Holdings Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/transmucosal-drug-delivery-devices-global-market-report

How Does The Transmucosal Drug Delivery Devices Market Perform Across Key Geographic Regions?

North America was the largest region in the transmucosal drug delivery devices market in 2024. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Transmucosal Drug Delivery Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16812&type=smp

Browse Through More Reports Similar to the Global Transmucosal Drug Delivery Devices Market 2025, By The Business Research Company

Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

Injectable Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

Implantable Drug Delivery Devices Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795